XML 33 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 8 - Stockholders' Equity
3 Months Ended
Nov. 30, 2018
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
8.
       STOCKHOLDERS’ EQUITY
 
On
October 24, 2018,
the Company’s Board of Directors declared a cash dividend of
$0.12
per share of NTIC’s common stock, payable on
November 21, 2018
to stockholders of record on
November 7, 2018
.
On
November 20, 2017,
the Company’s Board of Directors declared a cash dividend of
$0.10
per share of NTIC’s common stock, payable on
December 21, 2018
to stockholders of record on
December 8, 2018
.
 
During the
three
months ended
November 30, 2018
and
2017,
the Company repurchased
no
shares of its common stock.
 
The Company granted stock options under the Northern Technologies International Corporation Amended and Restated
2007
Stock Incentive Plan (the
2007
Plan) to purchase an aggregate of
70,884
shares of its common stock to various employees and directors during the
three
months ended
November 30, 2018.
The weighted average per share exercise price of the stock options is
$36.45,
which was equal to the fair market value of the Company’s common stock on the date of grant. During the
three
months ended
November 30, 2018,
no
stock options to purchase common stock were exercised.
 
The Company granted stock options under the
2007
Plan to purchase an aggregate of
47,252
shares of its common stock to various employees and directors during the
three
months ended
November 30, 2017.
The weighted average per share exercise price of the stock options is
$18.35,
which was equal to the fair market value of the Company’s common stock on the date of grant. During the
three
months ended
November 30, 2017,
stock options to purchase an aggregate of
1,500
shares of common stock were exercised at a weighted average exercise price of
$10.25
per share.
 
The Company issued
874
and
891
shares of common stock on
September 1, 2018
and
2017,
respectively, under the Northern Technologies International Corporation Employee Stock Purchase Plan (the ESPP).
 
The Company held its
2018
Annual Meeting of Stockholders (
2018
Annual Meeting) on
January 12, 2018.
At the
2018
Annual Meeting, a proposal to approve an amendment to the Company’s Restated Certificate of Incorporation to increase the Company’s authorized shares of common stock from
10,000,000
to
15,000,000
(Share Increase Amendment) was approved by the Company’s stockholders by the required vote. The Share Increase Amendment was filed with the Office of the Secretary of State of the State of Delaware on
January 16, 2018
and it became effective the same day. In determining that the Share Increase Amendment was approved by the required vote, votes cast by brokers, banks or other nominees without instruction from the beneficial owners of certain of our outstanding shares were counted in favor of the proposal in accordance with the rules of the New York Stock Exchange that govern how brokers
may
cast such votes. Because a disclosure in the definitive proxy statement for the
2018
Annual Meeting, which was filed on Schedule
14A
with the Securities and Exchange Commission (SEC) on
November 27, 2017 (
2018
Proxy Statement), anticipated that brokers would
not
have discretion to vote for the proposal to approve the Share Increase Amendment, a question has been raised as to the validity of the vote taken on the proposal to approve the Share Increase Amendment. The Company believes that the Share Increase Amendment was properly approved and is effective. However, because the description of the authority of brokers to vote on proposals without instruction in the
2018
Proxy Statement
may
create some uncertainty as to the effect of the vote obtained at the
2018
Annual Meeting and out of an abundance of caution, the Company is asking its stockholders at the
2019
Annual Meeting of Stockholders scheduled to be held on
January 18, 2019
to ratify the filing and effectiveness of the Share Increase Amendment pursuant to Delaware law in order to eliminate any uncertainty related to the effectiveness of the Share Increase Amendment. The Company has
not
issued, or reserved for issuance, and will
not
issue, or reserve for issuance, any of the additional
5,000,000
authorized shares as part of the Share Increase Amendment unless the vote at the
2019
Annual Meeting of Stockholders is in favor of the ratification of the Share Increase Amendment.